Navigation Links
Neuralstem Reports Second Quarter Financial Results and Highlights
Date:8/14/2008

$7,399,027 $7,826,053

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

Accounts payable and accrued expenses 936,110 1,016,699

STOCKHOLDERS' EQUITY

Preferred stock - -

Common stock 321,513 314,106

Additional paid-in capital 57,029,525 52,151,245

Accumulated deficit (50,888,121) (45,655,997)

Total stockholders' equity 6,462,917 6,809,354

Total liabilities and stockholders' equity $7,399,027 $7,826,053

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia.

Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego. The Company expects to file its first IND (Investigational New Drug) application with the FDA for ALS in the fall.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential ap
'/>"/>

SOURCE Neuralstem Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Neuralstem Fills Key Product Development Position
2. Neuralstem Responds to New StemCells, Inc. Lawsuit
3. Neuralstem Sues StemCells, Inc. Over New Patent
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
6. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
7. Neuralstem Shares Accepted for Trading on Amex(R)
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
10. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
11. Senetek PLC Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Convoy Therapeutics, Inc., a ... products to treat patients directly at the site ... SPACEā„¢ Technology Platform announced today that John Muraski, ... at the White Hat Life Science Investor Conferenceā„¢ ... Phoenix. In addition, interested individuals can meet ...
(Date:9/16/2014)... -- BCC Research reveals in its new ... the global market for stem cells is expected to ... five-year compound annual growth rate (CAGR) of 13.6%. The ... growth projections of $2.2 billion in 2014 to $3.9 ... Unlike other potential applications of bioscience, stem ...
(Date:9/15/2014)... Cancer Immunotherapy Market : ... Therapies is a new market research report announced ... principal types of therapeutics that have become the ... immunotherapy (which is often called "immuno-oncology") in recent ... cellular immunotherapy. , The regular use of ...
(Date:9/15/2014)... idea of fibers made of carbon nanotubes is neat, but ... The single-walled carbon nanotubes in new fibers created at Rice ... process designed by chemist Angel Mart and his colleagues. , ... results this month in the journal ACS Nano , ... together into a fiber. , Left to their own devices, ...
Breaking Biology Technology:Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3
... NeoGenomics, Inc. (OTC Bulletin Board: NGNM) today announced ... Equity Conference at 12:30 PM EDT on ... Hotel in Hollywood, FL.  Robert Gasparini, the Company,s ... NeoGenomics, market positioning, financial performance, and strategic direction and then ...
... /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,("China-Biotics", the "Company") (Nasdaq: CHBT ), the leading ... management will present at the Bank of America Merrill Lynch Health,Corporate Day. The ... Merrill,Lynch Client Service Center in Hong Kong . , ... About China-Biotics , ...
... ... The iuvo™ Chemotaxis Assay ... technology to provide quantitative measurements of neutrophil chemotaxis ( ... remains stable over the time period of the assay. ...
Cached Biology Technology:NeoGenomics to Present at Noble Financial's 6th Annual Equity Conference on Monday, June 7th 2NeoGenomics to Present at Noble Financial's 6th Annual Equity Conference on Monday, June 7th 3China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22 2BellBrook Labs Launches Groundbreaking New Microplate for High Content Chemotaxis Assays in a Stable Gradient 2BellBrook Labs Launches Groundbreaking New Microplate for High Content Chemotaxis Assays in a Stable Gradient 3BellBrook Labs Launches Groundbreaking New Microplate for High Content Chemotaxis Assays in a Stable Gradient 4
(Date:9/16/2014)... vessel returned to Spain culminating the around the world ... picture of how the global ocean works and what ... from the atmosphere is not limited to coastal areas, ... the planet, and it is already affecting the ocean ... in CSIC Residence for Researchers in Barcelona, in a ...
(Date:9/16/2014)... salmon-rich waters of Southeast Alaska to the white sand ... lumber and tourist towns, coastal residents around the U.S. ... divide along political lines. That,s a primary finding of ... published this month in the journal Society & ... environment-related differences from place to place to place. Each ...
(Date:9/16/2014)... are responsible for practically all vital functions in ... forward signals, transport particular substances and control immune ... proteins do not function independently of each other, ... examine the protein networks, you find many similarities ... from TUM,s Chair of Plant Systems Biology. "Some ...
Breaking Biology News(10 mins):The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 2The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 3Politics divide coastal residents' views of environment, UNH research finds 2Politics divide coastal residents' views of environment, UNH research finds 3Good networkers make prime targets 2
... Every process in a cell is affected by interactions ... body and their relationship to diseases is essential to ... Ontario Genomics Institute (OGI) is providing $100,000 through its ... Toronto (U of T),s Mammalian Membrane Two-Hybrid (MaMTH) project, ...
... Institution announced today that it is a grant recipient ... the Bill & Melinda Gates Foundation. Wolf B. ... with Bing Yang from Iowa State University and Frank ... health and development research project entitled "Transformative Strategy for ...
... recovery of UK butterfly populations to extreme drought is affected by ... in the landscape. The analysis, published this week in ... butterfly collected from 79 UK Butterfly Monitoring Scheme sites between 1990 ... 1995. The study was led by Dr Tom Oliver ...
Cached Biology News:Ontario Genomics Institute invests in validation of a novel protein interaction technology at U of T 2Carnegie Institution for Science receives Grand Challenges Explorations grant 2UK butterfly populations threatened by extreme drought and landscape fragmentation 2
TNF-R2 (L-20)...
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
... Columns, 10. *SizeSep 400 Spun Columns: For ... pairs in length. - ... in distilled water containing 0.15% Kathon CG/IcP Biocide. ... base pairs. *Extremely useful in the ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
Biology Products: